Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
7.32
+0.27 (3.83%)
Aug 23, 2024, 4:00 PM EDT - Market closed
Adverum Biotechnologies Revenue
In the year 2023, Adverum Biotechnologies had annual revenue of $3.60M.
Revenue (ttm)
$3.60M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
121
Market Cap
152.26M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amylyx Pharmaceuticals | 298.76M |
908 Devices | 52.69M |
Fennec Pharmaceuticals | 48.89M |
Capricor Therapeutics | 27.15M |
Century Therapeutics | 2.04M |
ADVM News
- 22 days ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 5 weeks ago - Adverum Biotechnologies, Inc's (ADVM) 26-Week Interim Analysis of the LUNA Phase 2 Trial Update Transcript - Seeking Alpha
- 5 weeks ago - Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual Meeting - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies to Participate in Upcoming May Investor Conferences - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting - GlobeNewsWire
- 5 months ago - Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates - GlobeNewsWire
- 6 months ago - Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire